Home › Funds › Propel Bio Management, LLC › UPB
Propel Bio Management, LLC position in UPB
UPSTREAM BIO INC · Health Care
Propel Bio Management, LLC reported holding 335,389 shares of UPB (UPSTREAM BIO INC) in its Q3 2026 13F filing — a position valued at US$1.8M, representing 0.94% of its reported portfolio and ranking #26 among its reported holdings. Propel Bio Management, LLC has disclosed UPB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Propel Bio Management, LLC's UPB position evolved
Propel Bio Management, LLC first disclosed a stake in UPB in Q1 2026 at 341,779 shares (US$3.1M). Across 3 filings, Propel Bio Management, LLC increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 335,389 shares valued at US$1.8M — a reduction of -15,000 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2026 | 341.78K | $3.10M | New |
| Q2 2026 | 350.39K | $2.42M | Add |
| Q3 2026 | 335.39K | $1.77M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About UPB and 13F data
UPB (UPSTREAM BIO INC) is a Health Care company. 50 other funds we track also report a position in UPB — the largest reported positions include ORBIMED ADVISORS LLC (US$39.4M), Decheng Capital LLC (US$18.9M), Enavate Sciences GP, LLC (US$17.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding UPB
- ORBIMED ADVISORS LLC 5.69M sh · $39.40M · Q2 2026
- Decheng Capital LLC 2.72M sh · $18.86M · Q2 2026
- Enavate Sciences GP, LLC 2.46M sh · $17.02M · Q2 2026
- Parkman Healthcare Partners LLC 935.25K sh · $6.47M · Q2 2026
- Bain Capital Life Sciences Investors, LLC 600.95K sh · $4.16M · Q2 2026
- Samsara BioCapital, LLC 353.72K sh · $2.45M · Q2 2026
More on Propel Bio Management, LLC
FAQ
How long has Propel Bio Management, LLC held UPB?
Propel Bio Management, LLC has disclosed UPB holdings in 3 of the last 3 reported quarters, going back to Q1 2026.
What is Propel Bio Management, LLC's current position in UPB?
As of Q3 2026, Propel Bio Management, LLC holds 335.39K shares of UPB (UPSTREAM BIO INC), valued at $1.77M, representing 0.94% of its reported portfolio and ranking #26.
Has Propel Bio Management, LLC been buying or selling UPB?
In the latest 13F filing (Q3 2026), Propel Bio Management, LLC reduced its position in UPB.
Which other funds hold UPB?
Other major institutional holders of UPB include ORBIMED ADVISORS LLC, Decheng Capital LLC, Enavate Sciences GP, LLC, among 50 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.